A detailed history of Swiss National Bank transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Swiss National Bank holds 83,900 shares of TNGX stock, worth $260,090. This represents 0.0% of its overall portfolio holdings.

Number of Shares
83,900
Previous 83,900 -0.0%
Holding current value
$260,090
Previous $719,000 10.15%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$6.66 - $10.15 $24,642 - $37,555
3,700 Added 4.61%
83,900 $719,000
Q4 2023

Feb 06, 2024

SELL
$6.52 - $12.01 $125,835 - $231,793
-19,300 Reduced 19.4%
80,200 $793,000
Q3 2023

Nov 08, 2023

SELL
$2.93 - $11.26 $46,001 - $176,782
-15,700 Reduced 13.63%
99,500 $1.12 Million
Q2 2023

Aug 09, 2023

BUY
$2.67 - $4.7 $28,302 - $49,820
10,600 Added 10.13%
115,200 $382,000
Q1 2023

May 10, 2023

SELL
$3.76 - $8.06 $46,248 - $99,138
-12,300 Reduced 10.52%
104,600 $413,000
Q4 2022

Feb 08, 2023

BUY
$3.41 - $8.29 $152,086 - $369,733
44,600 Added 61.69%
116,900 $847,000
Q2 2022

Aug 09, 2022

SELL
$3.86 - $8.01 $80,288 - $166,608
-20,800 Reduced 22.34%
72,300 $328,000
Q1 2022

May 09, 2022

BUY
$7.01 - $10.94 $44,864 - $70,016
6,400 Added 7.38%
93,100 $706,000
Q4 2021

Feb 08, 2022

BUY
$9.55 - $14.29 $827,985 - $1.24 Million
86,700 New
86,700 $948,000

Others Institutions Holding TNGX

About Tango Therapeutics, Inc.


  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $273M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.